Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Mallinckrodt
US Army
Dow
AstraZeneca
Baxter
QuintilesIMS
Fish and Richardson
Daiichi Sankyo
Accenture

Generated: January 23, 2018

DrugPatentWatch Database Preview

AMITRIPTYLINE HYDROCHLORIDE - Generic Drug Details

« Back to Dashboard

What are the generic sources for amitriptyline hydrochloride and what is the scope of amitriptyline hydrochloride patent protection?

Amitriptyline hydrochloride
is the generic ingredient in eighteen branded drugs marketed by Roche, Watson Labs, Astrazeneca, Bristol Myers Squibb, Warner Chilcott, Accord Hlthcare, Am Therap, Ani Pharms Inc, Copley Pharm, Halsey, Lederle, Mutual Pharm, Mylan, Par Pharm, Pliva, Purepac Pharm, Roxane, Sandoz, Sun Pharm Inds Inc, Superpharm, Teva, Ucb Inc, Usl Pharma, Vangard, Vintage Pharms, West Ward, Zydus Pharms Usa Inc, Anda Repository, Mylan Pharms Inc, Watson Labs Teva, Heritage Pharms Inc, Schering, Ivax Sub Teva Pharms, Sun Pharm Industries, and New River, and is included in one hundred and seventy-seven NDAs. Additional information is available in the individual branded drug profile pages.

There are thirteen drug master file entries for amitriptyline hydrochloride. Forty-five suppliers are listed for this compound.
Pharmacology for AMITRIPTYLINE HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for AMITRIPTYLINE HYDROCHLORIDE

US Patents and Regulatory Information for AMITRIPTYLINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE amitriptyline hydrochloride; perphenazine TABLET;ORAL 070374-001 Aug 25, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Copley Pharm AMITRIPTYLINE HYDROCHLORIDE amitriptyline hydrochloride TABLET;ORAL 088424-001 Apr 30, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ucb Inc AMITRIPTYLINE HYDROCHLORIDE amitriptyline hydrochloride TABLET;ORAL 085864-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ivax Sub Teva Pharms PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE amitriptyline hydrochloride; perphenazine TABLET;ORAL 070937-001 Sep 11, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharm Industries PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE amitriptyline hydrochloride; perphenazine TABLET;ORAL 071079-001 Nov 12, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pliva AMITRIPTYLINE HYDROCHLORIDE amitriptyline hydrochloride TABLET;ORAL 088884-001 Sep 26, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lederle AMITRIPTYLINE HYDROCHLORIDE amitriptyline hydrochloride TABLET;ORAL 086743-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Par Pharm AMITRIPTYLINE HYDROCHLORIDE amitriptyline hydrochloride TABLET;ORAL 088700-001 Sep 25, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pliva AMITRIPTYLINE HYDROCHLORIDE amitriptyline hydrochloride TABLET;ORAL 088883-001 Sep 26, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Roche ENDEP amitriptyline hydrochloride TABLET;ORAL 083639-005 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for AMITRIPTYLINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Astrazeneca ELAVIL amitriptyline hydrochloride INJECTABLE;INJECTION 012704-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Astrazeneca ELAVIL amitriptyline hydrochloride TABLET;ORAL 012703-007 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Astrazeneca ELAVIL amitriptyline hydrochloride TABLET;ORAL 012703-005 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Astrazeneca ELAVIL amitriptyline hydrochloride TABLET;ORAL 012703-006 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Astrazeneca ELAVIL amitriptyline hydrochloride TABLET;ORAL 012703-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Astrazeneca ELAVIL amitriptyline hydrochloride TABLET;ORAL 012703-003 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Astrazeneca ELAVIL amitriptyline hydrochloride TABLET;ORAL 012703-004 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
Cerilliant
Healthtrust
Boehringer Ingelheim
Medtronic
Julphar
Deloitte
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot